These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6528315)

  • 1. Electrochemical activity determination of trypsin-like enzymes. IX. Factor X and Factor Xa in plasma and whole blood.
    Szubarga A; Nigretto JM
    Thromb Res; 1984 Dec; 36(6):647-50. PubMed ID: 6528315
    [No Abstract]   [Full Text] [Related]  

  • 2. The assay of factor Xa on a centrifugal analyzer.
    Gram J; Jespersen J; Sidelmann J
    Thromb Res; 1984 Jan; 33(2):239-42. PubMed ID: 6367133
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of p-aminobenzamidine to monitor activation of trypsin-like serine proteases.
    Monroe DM; Sherrill GB; Roberts HR
    Anal Biochem; 1988 Aug; 172(2):427-35. PubMed ID: 3263815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of rat factors X and Xa: demonstration of factor Xa in rat plasma.
    Enjyoji K; Miyazaki K; Kato H
    J Biochem; 1991 Jun; 109(6):890-8. PubMed ID: 1718949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Simultaneous determination of zymogen activation time and zymogen level using chromogenic substrates in blood coagulation analysis].
    Svendsen L; Brogli M; Stocker K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):150-6. PubMed ID: 6177596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of factor Xa in vitro in human and mouse plasma and in vivo in mouse. Role of the endothelium and plasma proteinase inhibitors.
    Fuchs HE; Pizzo SV
    J Clin Invest; 1983 Dec; 72(6):2041-9. PubMed ID: 6196377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of human factor IXa activity in an isolated factor X activation system.
    Griffith MJ; Reisner HM; Lundblad RL; Roberts HR
    Thromb Res; 1982 Aug; 27(3):289-301. PubMed ID: 6814005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
    McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
    Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrophotometric determination of factor Xa generation in factor IX concentrates.
    Pepper DS; Banhegyi D; Howie A
    Thromb Haemost; 1977 Jun; 37(3):535-40. PubMed ID: 578033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of factor X and heparin with chromogenic substrate.
    Aiach M; Michaud A; Capron L; Fiessinger JN
    Acta Chir Scand Suppl; 1982; 509():109-13. PubMed ID: 6962612
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of synthetic inhibitors in coagulation physiological tests with peptide substrates].
    Stürzebecher J; Klessen C
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):157-60. PubMed ID: 6177597
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency.
    Bauer KA; Goodman TL; Kass BL; Rosenberg RD
    J Clin Invest; 1985 Aug; 76(2):826-36. PubMed ID: 3875633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrochemical activity determination of trypsin-like enzymes. VIII. Kallikrein and prekallikrein in plasma and whole blood.
    Corretge E; Nigretto JM
    Thromb Res; 1984 Dec; 36(6):563-70. PubMed ID: 6570370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are synthetic inhibitors able to improve factor Xa assays using peptide substrates?
    Stürzebecher J; Markwardt F; Wagner G; Voigt B
    Thromb Res; 1982 May; 26(3):221-6. PubMed ID: 7112515
    [No Abstract]   [Full Text] [Related]  

  • 15. Automated estimation of factor Xa using the chromogenic substrate S-2222.
    Madaras F; Chew MY; Parkin JD
    Haemostasis; 1981; 10(5):271-5. PubMed ID: 7274779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X.
    Castillo MJ; Kurachi K; Nishino N; Ohkubo I; Powers JC
    Biochemistry; 1983 Mar; 22(5):1021-9. PubMed ID: 6601494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amidolytic determination of Factor X in clinical plasma samples.
    Robijns P; Lijnen HR; Collen D
    Acta Clin Belg; 1983; 38(5):289-94. PubMed ID: 6659834
    [No Abstract]   [Full Text] [Related]  

  • 18. Experience with chromogenic substrates in studies of clotting and fibrinolytic systems.
    Chmielewska J; Latallo ZS
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):111-4. PubMed ID: 6177591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. erythro-beta-Hydroxyaspartic acid in bovine factor IX and factor X.
    Sugo T; Fernlund P; Stenflo J
    FEBS Lett; 1984 Jan; 165(1):102-6. PubMed ID: 6692907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant action of vanadate.
    Funakoshi T; Shimada H; Kojima S; Shoji S; Kubota Y; Morita T; Tominaga N; Ueki H
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):174-6. PubMed ID: 1576669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.